| arznei-telegramm

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

SPOT ON

Reduce the mighty carbon dioxide footprint of pressurized metered-dose inhaler … 1 metered-dose inhaler is equivalent to a 280 km car trip

NEW ON THE MARKET

New indication: upadacitinib (RINVOQ) for atopic dermatitis

Ofatumumab (KESIMPTA) in multiple sclerosis

THERAPY FROM A CRITICAL VIEWPOINT

Duration of platelet inhibition after percutaneous coronary intervention (PCI) in patients at high bleeding risk

a-t READERS QUESTIONS AND COMMENTS

Cannabidiol against osteoarthritis pain?

IN BRIEF

Dapagliflozin (FORXIGA) no longer approved for type I diabetes
free

SIDE EFFECTS

Myocarditis: Moderna vaccine no longer for people under 30 years of age

RAYNAUD syndrome with antibodies used for the prevention of migraine

Information on drug-induced QT prolongation is unsatisfactory

e a-t ON THE INTERNET

New indication: upadacitinib (RINVOQ) for atopic dermatitis (long version)

Ofatumumab (KESIMPTA) in multiple sclerosis (long version)

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles